Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord
- PMID: 2692753
- PMCID: PMC1854833
- DOI: 10.1111/j.1476-5381.1989.tb12667.x
Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord
Abstract
1. Neuropharmacological actions of all possible-state isomers of alpha-(carboxycyclopropyl)glycine (CCG), conformationally restricted analogues of glutamate, were examined for electrophysiological effects in the isolated spinal cord of the newborn rat. 2. Eight CCG stereoisomers demonstrated a large variety of depolarizing activities. Among them, the (2R, 3S, 4S) isomers of CCG (D-CCG-II) showed the most potent depolarizing activity, followed by the (2S, 3R, 4S) isomer (L-CCG-IV). 3. The depolarization evoked by L-CCG-IV, D-CCG-II and other D-CCG isomers was effectively depressed by N-methyl-D-aspartate (NMDA) antagonists. D-CCG-II was about 5 times more potent than NMDA in causing a depolarization. 4. The (2S, 3S, 4S) isomer of CCG (L-CCG-I) was more potent than L-glutamate in causing a depolarization of spinal motoneurones. The depolarization was slightly depressed by NMDA antagonists, but residual amplitudes of responses to L-CCG-I in the presence of NMDA antagonists We almost insensitive to 6,7-dinitro-quinoxaline-2,3-dione (DNQX) or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), suggesting that L-CCG-I might be a novel potent agonist. 5. After application of the (2S, 3S, 4R) isomer of CCG (L-CCG-III), responses to L-glutamate, D- and L-aspartate were markedly enhanced. The enhancement lasted for a period of several hours without a further application of L-CCG-III. 6. L-CCG-III also caused a depolarization, but it seemed unlikely that the potentiation of the glutamate response was directly related to the depolarization evoked by L-CCG-III. 7. The potentiation might be due to inhibition of uptake processes, but L-CCG-III was superior to L-(-)-threo-3-hydroxyaspartate, a potent uptake inhibitor of L-glutamate and L-aspartate, in enhancing the response to L-glutamate in terms of amplitude and duration of responses. 8. CCG isomers should provide useful pharmacological tools for analysis of glutamate neurotransmitter systems.
Similar articles
-
A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord.Brain Res. 1989 Feb 20;480(1-2):355-9. doi: 10.1016/0006-8993(89)90207-2. Brain Res. 1989. PMID: 2565750
-
Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.Brain Res. 1991 May 31;550(1):152-6. doi: 10.1016/0006-8993(91)90420-z. Brain Res. 1991. PMID: 1653635
-
Potentiation by DL-alpha-aminopimelate of the inhibitory action of a novel mGluR agonist (L-F2CCG-I) on monosynaptic excitation in the rat spinal cord.Br J Pharmacol. 1998 Feb;123(4):771-9. doi: 10.1038/sj.bjp.0701670. Br J Pharmacol. 1998. PMID: 9517398 Free PMC article.
-
A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Sep;103(1):13-7. doi: 10.1016/0742-8413(92)90220-2. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992. PMID: 1360366 Review.
-
Excitatory amino acids: physiological and pharmacological probes for neuroscience research.Acta Neurobiol Exp (Wars). 1993;53(1):43-51. Acta Neurobiol Exp (Wars). 1993. PMID: 8317271 Review.
Cited by
-
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries.Neurochem Res. 2019 Mar;44(3):516-530. doi: 10.1007/s11064-018-2640-6. Epub 2018 Oct 4. Neurochem Res. 2019. PMID: 30284673 Free PMC article.
-
A novel antagonist, phenylbenzene omega-phosphono-alpha-amino acid, for strychnine-sensitive glycine receptors in the rat spinal cord.Br J Pharmacol. 1994 Sep;113(1):165-70. doi: 10.1111/j.1476-5381.1994.tb16189.x. Br J Pharmacol. 1994. PMID: 7812607 Free PMC article.
-
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid.Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):371-6. doi: 10.1007/BF00169077. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7543185
-
Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum.Br J Pharmacol. 1993 Dec;110(4):1407-12. doi: 10.1111/j.1476-5381.1993.tb13977.x. Br J Pharmacol. 1993. PMID: 8306080 Free PMC article.
-
A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.Br J Pharmacol. 1993 Aug;109(4):1169-77. doi: 10.1111/j.1476-5381.1993.tb13745.x. Br J Pharmacol. 1993. PMID: 8401927 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources